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Three distinct developmental pathways for
adaptive and two IFN-γ-producing γδ T subsets in
adult thymus
Terkild Brink Buus 1, Niels Ødum 1, Carsten Geisler1 & Jens Peter Holst Lauritsen1
Murine γδ T cells include subsets that are programmed for distinct effector functions during
their development in the thymus. Under pathological conditions, different γδ T cell subsets
can be protective or can exacerbate a disease. Here we show that CD117, CD200 and CD371,
together with other markers, identify seven developmental stages of γδ T cells. These seven
stages can be divided into three distinct developmental pathways that are enriched for
different TCRδ repertoires and exhibit characteristic expression patterns associated with
adaptive (γδTn), IFN-γ-producing (γδT1) and IFN-γ/IL-4-co-producing γδ T cells (γδNKT).
Developmental progression towards both IFN-γ-producing subsets can be induced by TCR
signalling, and each pathway results in thymic emigration at a different stage. Finally, we
show that γδT1 cells are the predominating IFN-γ-producing subset developing in the adult
thymus. Thus, this study maps out three distinct development pathways that result in the
programming of γδTn, γδT1 and γδNKT cells.
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γδ T cells are a heterogeneous population with diverse effectorfunctions during anti-microbial and anti-tumoural respon-
ses1–3. γδ T cells show great promise in anti-tumour
immunotherapy4. However, while cytotoxic and IFN-γ-producing
γδ T cell effector subsets elicit potent anti-cancer effects, other γδ
T cell effector subsets have pro-oncogenic functions and are
associated with poor prognoses4, 5.
Unlike conventional αβ T cells, the effector functions of some
γδ T cells are programmed during their development in the
thymus1. The γδ T cell effector subsets can be divided based on
their ability to produce either IL-17 (γδT17), IFN-γ (γδT1) or
both IL-4 and IFN-γ (γδNKT)1. Whereas both of the IFN-γ-
producing subsets γδT1 and γδNKT have been shown to be
dependent on strong T cell receptor (TCR) signals during their
development, γδT17 cells have been reported to develop in the
absence of TCR ligand selection6–9. Additionally, studies have
identiﬁed a population of γδ T cells that exhibit adaptive-like
characteristics. Analogous to conventional αβ T cells, these
adaptive γδ T cells are believed to be exported from the thymus as
naive (γδTn) cells that require peripheral priming for functional
development, and can establish long-lasting TCR-dependent
memory2, 10–13. While the development of γδTn cells is still
largely undescribed, they have been suggested to develop in the
absence of TCR ligand selection and to be exported with a naive
(CD62L+CCR7+CD44−) surface phenotype12, 14, 15.
The development of γδ T cells is initiated in the foetus and
continues throughout life. Foetal and adult γδ T cell development
may be considered two distinct systems that involve distinct
progenitor waves16, 17 and require specialised thymic micro-
environments6, 18, expressing distinct γδTCR repertoires and
resulting in distinct effector subsets[18–21]. The dendritic epi-
dermal T cell (DETC) subset, the natural γδT17 subset and a
majority of the γδNKT subset develop only during foetal and
perinatal life18, 21, 22. In adult mice, the effector subsets that
develop are predominantly adaptive γδTn cells and IFN-γ-
producing γδT1 and γδNKT cells, most of which utilise either the
Vγ1.1 or the Vγ2 segment in their TCR23 (V segment nomen-
clature as in ref. 24).
αβ T cell progenitors can be divided into several distinct sub-
populations based on their surface marker expression. These
different subpopulations are correlated with distinct development
checkpoints. By contrast, few surface markers have been identi-
ﬁed on developing γδ T cells25. Most studies have solely used
CD24 to distinguish immature (CD24high) and mature (CD24low)
γδ thymocytes. Previous studies have further shown that CD25
marks a small population of highly immature γδTCR-expressing
progenitors, and that CD73 marks γδ thymocytes that are com-
mitted to the γδ lineage8, 26, 27.
Over the years, advances have been achieved in our under-
standing of how IL-17 vs. IFN-γ programming is determined in the
thymus. This includes the identiﬁcation of robust surface markers
that distinguish IL-17 and IFN-γ-producing cells in the periphery
and the perinatal thymus6–9, 28–30. However, in the adult thymus,
where most of the γδ thymocytes are CD24high, these markers pri-
marily mark terminally differentiated or long-lived effector cells
reminiscent of the perinatal stage, which are CD24low18,31,32. These
differences between γδ T cell development in the foetal and adult
thymus and the scarcity of surface markers dividing the CD24high
population, prompted us to identify additional surface markers to
further segregate developing γδ T cells in the adult thymus.
In this study, we characterise CD117, CD200 and CD371 as
surface markers that are expressed during γδ T cell development.
Together with CD24, CD25 and CD73, these markers establish
seven distinct development stages that are found in both the
Vγ1.1+ and Vγ2+ subset. These seven stages can be divided into
three pathways exhibiting different global gene transcription,
including the expression of cytokines and transcription factors
associated with γδTn, γδT1 and γδNKT cells. We show that cells
within the three identiﬁed pathways display distinct TCRδ
repertoires, and that progression through the pathways resulting
in IFN-γ-producing effector cells can be induced by TCR sig-
nalling. Blocking thymic emigration causes an accumulation of γδ
T cells at three stages representing the thymic end points of each
pathway. The surface phenotypes of these end points indicate that
γδTn and γδT1 cells are exported while still expressing CD24.
Finally, although γδNKT cells are the major IFN-γ-producing
subset in the thymus during homoeostasis, we show that
γδT1 cells are the predominant IFN-γ-producing subset under-
going development in the adult thymus. Thus, this study maps
out three distinct developmental pathways that result in pro-
gramming of γδTn, γδT1 and γδNKT cells.
Results
Identiﬁcation of additional markers of γδ development. Studies
of how and when different γδ thymocytes branch off and diverge
towards different effector fates have been hampered by the
scarcity of surface markers distinguishing different γδ thymocyte
development stages in the adult thymus25. To identify additional
development markers, we analysed our previously published data
set, GSE7592031, for genes encoding surface proteins that are
differentially expressed by the CD24highCD73− and
CD24highCD73+ populations in both the Vγ1.1+ and Vγ2+ sub-
sets (Fig. 1a, b and Supplementary Fig. 1a–c). Surface expression
of the gene products was veriﬁed by ﬂow cytometry yielding three
markers that can further segregate CD24high γδ thymocytes:
CD117 (c-Kit), CD200 (OX-2) and CD371 (Clec12a) (Fig. 1c–e).
New markers allow isolation of seven distinct γδ populations.
Current developmental stages deﬁned by CD24 (HSA), CD25 (IL-
2Rα) and CD73 (Nt5e) are insufﬁcient to delineate the develop-
ment of γδ thymocytes towards different effector fates. To
establish additional development stages, we examined the co-
expression of CD117, CD200 and CD371 with CD24, CD25 and
CD73. Unlike classical bi-axial ﬂow cytometric plots, parameter
reduction by t-distributed stochastic neighbour embedding
(t-SNE) allowed visualisation of the co-expression of all six
markers on individual cells. Figure 2a shows t-SNE-clustered cells
coloured by their expression of each of the six markers. To
identify distinct populations based on the expression of all six
markers, we divided the cells into populations using automated
clustering algorithms (Supplementary Fig. 2a). The best clustering
was constructed by FlowSOM, dividing the total γδ thymocyte
pool into seven distinct populations that are referred hereafter to
as populations A through G (Fig. 2b, c). These populations were
all present in mice from 1 to 28 weeks of age (Fig. 2d and Sup-
plementary Fig. 2b). Furthermore, Vγ1.1+ and Vγ2+ progenitors
were present in all seven populations, albeit with different dis-
tributions (Fig. 2e, f and Supplementary Fig. 2c). We could also
gate each of the seven populations by conventional bi-axial ﬂow
cytometry gating (Fig. 2g). To determine how the identiﬁed
populations relate to previously described γδ T cell populations,
we investigated the expression of CCR6, CD5, CD27, CD44,
CD45RB, CD122, CD127, NK1.1 and Ly-6C within each of the
seven populations7, 8, 10, 28, 29, 33. We found that although they
were differentially expressed, the existing markers were not suf-
ﬁcient to separate populations A to G (Fig. 2h–j and Supple-
mentary Fig. 2d, e). Thus, co-expression of CD117, CD200 and
CD371 together with CD24, CD25 and CD73 allowed the isola-
tion of seven distinct γδ thymocyte populations.
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Developing γδ T cells branch into effector populations. Effector
programming of γδ thymocytes is controlled at the transcrip-
tional level, segregating the effector subsets with characteristic
expression of distinct cytokines, signalling molecules and tran-
scription factor networks6, 17, 32, 34–36. Consequently, we hypo-
thesise that γδ thymocytes developing towards different effector
fates cannot follow a direct sequential development but must
branch into different development pathways as they diverge. To
assess the relationship between the seven populations and effector
programming, we sorted the Vγ1.1+ and Vγ2+ subsets of each
population by ﬂow cytometry (Supplementary Fig. 3a) and per-
formed RNA-Seq using their total mRNA. This procedure
enabled us to determine the transcriptional similarity of each
population, and subsequently allowed us to link the transcrip-
tional characteristics expressed in each population with their
established functions in effector programming. We calculated the
pairwise Euclidian distances between each of the populations as a
measure of their individual transcriptional differences (Fig. 3a, b).
By connecting the least transcriptionally different populations, we
constructed models of how the populations were most likely to be
related (Fig. 3c, d). Most populations showed high transcriptional
similarity to more than one subsequent population, which indi-
cated that progression through the A to G stages might not follow
a sequential linear path but rather branch into different pathways
as predicted in our hypothesis. This branching pattern was fur-
ther supported by PCA analysis of the RNA-Seq data sets (Fig. 3e
and Supplementary Fig. 3b–e), as well as by single-cell expression
of CD24, CD25, CD73, CD117, CD200 and CD371 by ﬂow
cytometry analysed using two different algorithms that are used
for inferring cellular progression: Isomap and Diffusionmap
(Fig. 3f and Supplementary Fig. 3f)37.
Subsequently, we investigated the expression of genes char-
acteristic of γδ T cells programmed for distinct effector function
(Fig. 3g). The expression of genes associated with TCR ligand
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differentially expressed between CD24+CD73− and CD24+CD73+ cells. Data from public data set GSE75920 (three to four individual experiments from
sorted cells, each pooled from 30 mice). Expression of genes marked in bold was veriﬁed by ﬂow cytometry. Expression of red and blue genes is shown in
c–e, and expression of remaining bold genes is shown in Supplementary Fig. 1. c–e Representative ﬂow cytometric plots showing expression of c CD117, d
CD200 and e CD371 on TCRδ+-gated thymocytes as histograms (left), distribution of marker negative and positive cells within development stages deﬁned
by CD73 and CD24 (centre) and expression of markers within development stages of the Vγ1.1+ and Vγ2+ subsets (right)
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independent (γδT17 and γδTn) and TCR ligand-dependent
(γδT1 and γδNKT) programming clearly segregated the A, B and
C populations from the E, F and G populations, respectively.
Remarkably, the E and G populations each expressed distinct
gene sets associated with γδT1 and γδNKT cells, respectively
(Fig. 3g). While most of the genes related to TCR ligand
independent γδT17 and γδTn programming were highly
expressed by the B and C populations, a subset of these genes,
including the IL-17A and F genes themselves, were primarily
expressed by the Vγ2+ G population, which is known to contain
the majority of thymic resident γδT17 cells, reminiscent of
perinatal development32. To verify the RNA-Seq expression at the
protein level, we analysed the expression of RORγ(t) (encoded by
Rorc), PLZF (encoded by Zbtb16) and AHR within the
populations by ﬂow cytometry, which conﬁrmed the segregation
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of effector-related proteins between populations (Supplementary
Fig. 3g–i).
In addition to their expression of distinct transcriptional
networks, different γδ T cell effector subsets are enriched for
certain TCR sequences. Thus, we next determined if the
segregation of the populations into effector subsets was
accompanied by the corresponding CDR3 motifs (Fig. 3h). The
consensus γδNKT CDR3δ sequence was represented in more
than half of the TCRδ transcripts within the Vγ1.1+ G
population. CDR3 motifs related to γδT17 cells were all highly
enriched within the Vγ2+ G population19, 20. The T10/T22-
binding motif was highly enriched within the E population from
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both the Vγ1.1+ and the Vγ2+ subset. T10/T22-reactive γδ T cells
constitute up to 1% of the γδ thymocyte pool and are prototypical
γδT1 cells7. Finally, the germline Vγ2Jγ1 motif associated with
γδT17 cells and a PE-binding CDR3δ motif associated with the
γδTn cell subset12 were both selectively reduced within the E and
F populations in concordance with γδT17 and γδTn cells being
programmed in the absence of TCR ligand selection (Fig. 3h).
Together, these phenomena show that developing γδ T cells
branch into populations with distinct effector characteristics.
Based on these data, we propose a model of γδ T cell development
in which γδ T cell progenitors from both the Vγ1.1+ and Vγ2+
subset encounter multiple checkpoints during their development
that direct them to progress through distinct pathways. Based on
evidence from previous studies6, 7, 9, 29, the selection of TCR
ligands or the lack thereof is likely to constitute at least one of
these checkpoints. Finally, we hypothesise that progression
through these different pathways facilitates the programming
and export of γδ T cells with distinct effector functions.
TCR signalling induces progression through the D–F stages.
TCR selection is known to direct effector programming towards
the IFN-γ-producing subsets6, 7, 9, 29. Accordingly, if the E and G
populations are indeed thymic precursors of γδT1 and
γδNKT cells, respectively, TCR stimulation should direct γδ
thymocytes to progress through the pathways resulting in these
populations. These pathways are marked by initial CD200
induction (population D) followed by CD73 expression with or
without CD117 expression (populations E or F) and eventually
downregulation of CD24 (population G). To test this phenom-
enon, we sorted cells from each of the A to G populations and
cultured them for 2 days on OP9-DL1 monolayers in the presence
or absence of anti-CD3 stimulation. While CD25 marks the
earliest TCRδ+ cells in the thymus8, 26, it is also known to be
induced on most T cells after anti-CD3 stimulation in vitro.
Indeed, CD25 was induced by anti-CD3 stimulation in all sam-
ples, irrespective of which population that was initially sorted,
thus obscuring the distinction of true population A cells (Fig. 4a,
b). To avoid faulty classiﬁcation, we merged the A and B popu-
lations in the analysis, both deﬁned by being CD371+CD73−
(Supplementary Fig. 4a). In cells sorted from the A, B and C
populations, TCR stimulation induced expression of CD200,
CD117 and CD73 (Fig. 4a, b). In contrast, cells sorted from the D,
E, F and G stages were largely unaffected by TCR stimulation
(Fig. 4c and Supplementary Fig. 4b, c). This result suggests that
progression through the CD200-expressing (D, E and F) stages is
induced by TCR signalling, in agreement with these cells being
precursors of IFN-γ-programmed effectors. Concordantly, the D,
E and F populations expressed high levels of TCR ligand-induced
genes (Fig. 4d)9. The G populations were unaffected by TCR
signalling and did not express hallmarks of recent TCR signalling
ex vivo (Fig. 4a–d).
We hypothesised that populations undergoing thymic TCR
ligand selection would exhibit different TCR repertoires than
would cells developing in the absence thereof. According to their
transcriptional proﬁles and the TCR inducibility of CD200, the D,
E and F populations would be expected to express different TCR
sequences than those found in the B and C populations. To assess
this scenario, we analysed the expression of TCR Vδ within the
populations of the RNA-Seq data set. We found that the D, E and
F populations were highly enriched for certain TCR Vδ sequences
(Trav21/dv12, Trav15-1/dv6-1, Trdv5 and Trav13-4/dv7) com-
pared with the B and C populations (Fig. 4e). These data are all
consistent with the D, E and F populations being TCR ligand-
selected precursors of IFN-γ-programmed effectors.
γδ T cells emigrate from the thymus at three stages. The gene
expression proﬁles suggest that E and G are the terminal popu-
lations in the γδT1 and γδNKT pathways, respectively, and
should be ready to emigrate from the thymus. Furthermore, as
γδTn cells are believed to develop in the absence of TCR ligand
selection, we hypothesised that either B or C could be the
terminal population for these pathways. To test these hypotheses,
we blocked S1P1-mediated thymic export by treating mice with
the S1P1 antagonist FTY72038. Blocking thymic export should
result in thymic accumulation of cells within the B/C, E and G
populations and their subsequent depletion from the peripheral
lymph nodes. In mice treated with FTY720, we observed an
accumulation of cells within the C, D, E, F and G populations
after 5 days of treatment (Fig. 5a, b and Supplementary Fig. 5a, b).
From day 5 to day 10, the D and F populations increased only
slightly, whereas the C, E and G populations continued to accu-
mulate and increased to levels that were ten-, ﬁve- and tenfold
higher than in the untreated mice, respectively. Concurrent with
their accumulation, after FTY720 treatment the C and E popu-
lations displayed downregulated CD24 levels comparable to
mature γδ T cells in the periphery (Fig. 5c and Supplementary
Fig. 5c). While most peripheral γδ T cells express low levels of
CD24, a large proportion of the γδ T cell recent thymic emigrants
(γδRTEs) are CD24high when they reach their target organs, upon
which they downregulate their CD24 expression39. The presence
of CD24low cells within the C and E populations, solely when
thymic export was blocked, suggested that at homoeostasis these
populations are exported while still expressing high levels of
CD24. To assess whether the accumulation of cells within the C
and E populations causes subsequent depletion of CD24high
γδRTEs in the periphery, we analysed the expression of CD24 and
CD73 on peripheral γδ T cells in inguinal lymph nodes (iLN)
after FTY720 treatment. In untreated mice, we found CD24high
γδRTEs within both CD73−- and CD73+-gated cells corre-
sponding to the expression pattern of the thymic C and E
populations, respectively (Fig. 5d, e and Supplementary Fig. 5d).
Both CD24high γδRTEs populations were signiﬁcantly depleted in
the iLN when thymic emigration was inhibited. These results
show that γδ thymocytes accumulate at the C, E and G stages in
the thymus and are subsequently depleted from the periphery
when thymic emigration is inhibited. This phenomenon is con-
sistent with the cells from the C, E and G populations constituting
terminal populations of three distinct pathways that lead to the
export of γδTn cells, γδT1 cells and γδNKT cells, respectively.
The C population exhibits hallmarks of γδTn cells. Both γδT17
and γδTn cells are believed to develop in the absence of TCR
ligand selection6, 7, 9, 14, 29. As γδT17 cells are restricted to
develop only during perinatal life18, we hypothesised that the cells
developing through the C pathway in adult mice represent the
γδTn cell subset. In this case, the number of IL-17A-producing γδ
T cells should remain unchanged, despite the accumulation of the
C population after FTY720 treatment. Thus, we analysed the
expression of IL-17A and IFN-γ within the accumulating γδ
thymocytes after FTY720 treatment and found that while the
number of IFN-γ+ γδ T cells was increased 14-fold, the number of
IL-17A+ γδ T cells was unchanged (Fig. 6a–c and Supplementary
Fig. 6a, b). Furthermore, the C populations expressed high levels
of Ccr7 and Sell (encoding CD62L) and low levels of Cd44. This
Ccr7highSellhighCd44low phenotype is associated with γδTn cells
and contrasts the memory-like Cd44high γδT17 phenotype
(Fig. 3g). Consequently, despite their independence of TCR ligand
selection, their expression of γδT17-related genes and their
enrichment for γδT17-related CDR3 motifs, the cells from the C
populations did not produce IL-17A and expressed a naive
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surface phenotype. This ﬁnding indicates that the cells in the C
population are likely progenitors of γδTn cells.
γδT1 are the predominant developing IFN-γ-producing subset.
Unlike IL-17A+ γδ T cells, IFN-γ+ γδ T cells drastically accu-
mulated in the adult thymus after FTY720 treatment (Fig. 6a–c).
As IFN-γ is produced by both γδT1 and γδNKT cells, we next
wanted to determine if the accumulating IFN-γ+ cells belong to
the γδT1 or γδNKT subset. Thus, we co-stained the accumulating
IFN-γ+ cells with the γδNKT markers PLZF and NK1.1, as well as
CD45RB, which has been associated with γδT1 cells28, 40, 41.
While few of the accumulating IFN-γ+ cells co-expressed NK1.1+
and PLZF+, most of the accumulating IFN-γ+ cells were
CD45RBhi, NK1.1− and PLZF− (Fig. 6d, e). Consequently, a larger
proportion of the cells from the F populations must progress to
the E stage and become γδT1 cells rather than γδNKT cells. This
possibility is further supported by the higher similarity between
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the E and F populations than between the F and G populations, at
the surface marker level, at the transcriptional level and at the
TCR repertoire level (Figs. 3 and 4e). Consequently, while
γδNKT cells within the G population constitute the majority of
the thymic resident IFN-γ-producing γδ T cells, they are not a
major actively developing effector subset in the adult thymus.
Consistent with the G populations primarily containing long-
lived resident effector cells at homoeostasis, the G populations
showed the lowest TCR diversity and were largely oligo-clonal
(Supplementary Fig. 7a–d). The higher propensity of F popula-
tion cells to develop towards the γδT1 subset rather than γδNKT
subset is further emphasised by the reduction in Vδ6.3+ fre-
quency within the Vγ1.1+ G population after FTY720 treatment
(Fig. 6f, g). In fact, while the A through F populations maintained
similar Vδ6.3+ and Vδ4+ frequencies after FTY720 treatment, this
was not the case for the G populations (Fig. 6f–i). Taken together,
these ﬁndings show that γδT1 cells are the predominant IFN-γ-
producing subset developing in the adult thymus.
Discussion
Studies of how and when different γδ thymocytes branch off and
diverge towards different effector fates in the adult thymus have
been hampered by the scarcity of surface markers distinguishing
different γδ thymocyte developmental stages25. In this study, we
characterise three new development markers, CD117, CD200 and
CD371, allowing the identiﬁcation of seven γδ thymocyte popu-
lations within both the Vγ1.1+ and the Vγ2+ subset. We used this
improved resolution to establish three developmental pathways
that lead to the development of distinct γδ T cell effector subsets
exhibiting hallmarks of IFN-γ-producing (γδT1), IFN-γ/IL-4-co-
producing (γδNKT) and adaptive (γδTn) γδ T cells (Fig. 7).
Several surface markers expressed by different γδ T cell effector
populations are well established. However, while these markers
are invaluable for distinguishing effector populations in the per-
iphery and foetal thymus, they do not clearly distinguish devel-
oping γδ thymocytes in the adult thymus. In fact, many of these
markers primarily segregate the effector cells contained within the
G populations, many of which appear to be long-lived resident
effector cells. CD44, CD45RB and CD122 are upregulated in the
E, F and G populations believed to be selected by the TCR in a
pattern similar to CD73. However, neither CD44, CD45RB nor
CD122 could separate the populations as clearly as CD73. Fur-
thermore, the existing markers were unable to distinguish the C
and D populations from the B population in the absence of
CD200 and CD371, and could not segregate the E from the F
population without the detection of CD117.
Due to the lack of development markers and a focus on the
foetal system, most previous studies have focused solely on
CD24low cells as the thymic end point of γδ T cell development32,
42, 43. This is despite strong and long-standing evidence of CD24
expression within the majority of γδ T cell recent thymic emi-
grants (γδRTEs) in adult mice39, 44. These CD24high γδRTEs have
been shown to constitute approximately half of the total γδ T cell
populations in peripheral lymphoid organs and to be con-
tinuously replenished39. In this study, we identiﬁed two popula-
tions of CD24high γδ thymocytes, stages C and E, which
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accumulated when thymic export was blocked. Additionally, we
found that these accumulated populations downregulated CD24
only when their export was pharmacologically blocked. This
result is analogous to γδRTEs, which are known to downregulate
CD24 after they arrive at their target organs in the periphery39.
Concurrent with the thymic accumulation of cells within the C
and E stages, we observed selective depletion of CD24high γδ
T cells in the peripheral lymph nodes after FTY720 treatment.
Consistent with thymic export at both the (CD73−) C and
(CD73+) E stages, the CD24high γδRTEs were equally distributed
between CD73− and CD73+ cells in the peripheral lymph nodes.
Taken together, these ﬁndings support the occurrence of thymic
export at the C and E stages and establish a gating strategy that
will allow future studies to discriminate immature developing
CD24high cells from cells that exit the thymus while still expres-
sing CD24.
Effector programming of γδ T cells is coupled to TCR signals
received during their development6, 7, 9. While the ligands for
most γδTCRs are still unknown, sequencing technologies have
increased the number of known complementarity-determining
region three (CDR3) motifs associated with γδT1, γδT17 and
γδNKT cells19–21, 45, 46. Here we found that TCR signal-
ling directed development to proceed through the D, F and E
stages, and we showed that the TCR repertoires were highly
different between the TCR ligand-dependent and -independent
stages. Furthermore, we showed that known sequence motifs of
prototypical TCR ligand-dependent T10/T22-reactive γδT1 cells
were enriched within the D, F and E population, with a con-
comitant depletion of motifs related to TCR signalling naive
γδT17 and γδTn cells7, 19, 20. The E stages expressed the highest
levels of Id3, Lag3 and Tigit, as well as the lowest levels of Sox13,
Bcl11b and Thy1. This proﬁle has been shown to be induced by
TCR ligand selection of γδ intraepithelial lymphocytes (γδIELs)
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in the gut and skin6, 47. Intriguingly, the E stages also express high
levels of Ahr, which, together with CD117, is expressed by both
epidermal and gut IFN-γ-producing γδIELs (GSE8542247; Imm-
Gen.org; Kadow, Jux48). Similar to the T10/T22-reactive
γδT1 cells, these γδIEL populations are selected by known
ligands. This supports that the upregulation of CD117 is a
common trait for γδT1 cells6, 7, 9. Unlike the IFN-γ-producing
subsets, it has been hypothesised that γδT17 cells and γδTn cells
develop and are exported in the absence of TCR selection by
endogenous ligands6, 7, 10, 14. When thymic export was blocked,
we observed an accumulation of cells within the C population
with an apparent TCR ligand-naive phenotype expressing genes
associated with γδTn and γδT17 programming. However, despite
having the associated transcriptional networks32, 35, these cells
did not produce IL-17A upon stimulation. Unlike γδT17 cells, the
C population exhibited hallmarks of γδTn cells (Ccr7highSell-
highCd44low), further indicating that the C population contains
mature γδTn cells. Consequently, our data suggest that similar
transcriptional networks are active in the development of γδTn
and γδT17 cells and support that expression of these transcrip-
tional networks are insufﬁcient to allow IL-17A programming in
the adult thymus18, 22. The G population contains a mixture of
γδNKT and γδT17 cells that are enriched within the Vγ1.1+ and
Vγ2+ subset, respectively, as evidenced by their transcriptional
proﬁles and the expression of CD27, CD44, CCR6 and NK1.1
associated with these effector populations8, 28. We found that
only the G populations had an altered proportion of Vδ6.3/2+
and Vδ4+ cells after FTY720 treatment and were highly enriched
or oligo-clonal for semi-invariant TCR sequences at homo-
eostasis. Furthermore, while IFN-γ-producing cells readily accu-
mulated in the adult thymus, we observed no accumulation of IL-
17A-producing cells. This ﬁnding suggests that, at homoeostasis,
the G populations contain a large proportion of long-lived resi-
dent effector cells that have not recently undergone thymic
development. This phenomenon is consistent with the restriction
or bias of γδT17 and γδNKT cells towards development during
the perinatal stage, respectively18, 21. Consequently, studies
should be careful when comparing actively developing γδ thy-
mocytes with resident effector γδ T cells included in the G
population, and we strongly recommend including CCR6 and
NK1.1 to further distinguish the two effector subsets contained in
the G population. However, unlike γδT17 cells, γδNKT cells do
develop in the adult thymus, and thus we have denoted the
actively developing part of the G population as the thymic pre-
cursors of γδNKT cells in our proposed developmental model
(Fig. 7).
The development of γδNKT cells is known to be dependent on
strong TCR signalling required for induction of ThPOK and
PLZF41, 42, 49, 50. The mechanism that determines whether a cell
progresses towards the γδT1 or γδNKT effector fate, both of
which are dependent on strong TCR signals during development,
remains poorly deﬁned. Differential dependence on Id3 and
SLAM/SAP signalling as well as distinct progenitor origins have
been suggested41, 51, 52. A previous study has also shown that the
development of γδNKT cells is dependent on TCR signalling
induced by outside-in conformational changes, whereas other
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Fig. 7 γδTn, γδT1 and γδNKT cells develop through three distinct pathways in the adult thymus. Suggested model of γδ T cell development divided into the
A to G stages deﬁned by the expression of CD117, CD200 and CD371 together with CD24, CD25 and CD73. The A stage deﬁnes the earliest γδTCR-
expressing progenitors, which develop towards the B and C populations and eventually result in the export of TCR-naive adaptive γδ T cells (γδTn).
Encounter with cognate TCR ligands induces TCR selection, shifting the cells to progress through the D and F stages. TCR-selected γδ thymocytes will then
progress to the E or G stage, resulting in the export of IFN-γ-producing (γδT1) or IFN-γ/IL-4-co-producing (γδNKT) cells, respectively. The C, E and G
stages are characterised by the distinct expression of key factors involved in effector programming, including characteristic transcription factor networks
and cytokines, and display highly focused TCR Vδ repertoires. IL-17-producing (γδT17) cells do not develop in the adult thymus, but long-lived resident
γδT17 cells are included in the G population at homoeostasis and can be distinguished by their expression of CCR6
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IFN-γ-producing γδ T cells are not53. Interestingly, the hallmarks
of γδNKT cells, including the expression of Il4, Zbtb7b (encoding
PLZF) and Zbtb16 (encoding ThPOK) as well as TCRVδ6.3, were
all speciﬁcally enriched in the Vγ1.1+ G population as well as a
small fraction of the F population, but not within the E popula-
tion. Thus, we have shown that TCR-selected γδ thymocytes
progressing towards γδNKT or γδT1 cells can be distinguished by
their differential expression of CD117. Interestingly, this dis-
tinction between γδNKT and γδT1 is emphasised in our results
by a dichotomy in the expression of Id2 and Id3 between G and E
stages that are known to be involved in the development of these
subsets41, 54. When thymic export was blocked, we found a
drastic accumulation of IFN-γ-producing γδ T cells. Remarkably,
most of these cells were negative for PLZF and NK1.1 and
expressed high levels of CD45RB, consistent with their status as
γδT1 cells. This ﬁnding indicates that homoeostatic development
in adult mice favours the γδT1 over the γδNKT effector fate, yet
we cannot exclude the possibility that some IFN-γ is produced by
γδTn cells that are activated by short-term stimulation, as shown
for peripheral CD27+ γδ T cells8. The bias towards γδT1 devel-
opment in adult mice may seem contradictory to the γδNKT
phenotype dominating the mature (CD24low) population in the
thymus at homoeostasis. However, within the Vγ1.1+ G popula-
tion, we found high proportions of germline-like Vδ6.3
CDR3 sequences that were characteristic of γδNKT cells devel-
oping during the perinatal period, where TdT is not expressed21.
Furthermore, we showed that the proportion of cells expressing
the prototypical Vγ1.1Vδ6.3+ within the G population was
markedly diluted by other TCRVδ-bearing Vγ1.1+ cells when
thymic export was blocked. A similar trend was observed in the
resident γδT17 population dominating the Vγ2+ G population at
homoeostasis. In this population, we observed marked enrich-
ment in germline CDR3 sequences associated with γδT17 cells,
which are known to develop during the perinatal period18–20.
This ﬁnding indicates that the G populations, at homoeostasis,
contain long-lived resident γδ T effector cells that developed
during the perinatal period, as observed in many other immune
and peripheral organs18.
In conclusion, this study presents three new markers that allow
the identiﬁcation of seven distinct developmental stages of γδ
T cells. We provide data supporting that these stages branch into
three pathways that result in the programming and export of
γδTn, γδT1 and γδNKT cells. The functions of these effector
subsets are highly specialised and provide immunity against
various pathogens and transformed host cells. Thus, we present a
framework for investigating the processes that precede effector
programming. We believe that this framework will allow future
studies to gain further insight and determine how we can shape
and utilise our γδ T cell pool towards the most beneﬁcial effector
responses.
Methods
Mice and FTY720 treatment. Unless stated otherwise, all mice experiments were
conducted using 7- to 8-week-old female C57BL/6 mice obtained from Taconic
(B6-F; Ry, Denmark) and housed in speciﬁc pathogen-free facilities at the
Department of Experimental Medicine, Faculty of Health and Medical Sciences,
University of Copenhagen, in accordance with the national animal-protection
guidelines (approved by the Danish Veterinary and Food Administration; license
no. 2012-15-2934-00663). To analyse 1-, 2- and 3-week-old mice, litters with mixed
genders were used. Mice were killed by careful cervical dislocation to avoid
bleeding into the thymus. Standard deviation was established in pilot experiments.
We used two to four mice for phenotypic characterisation.
In the FTY720 experiments, mice were randomly assigned to treatment groups,
and 2.5 µg per mL FTY720 (Sigma-Aldrich) was added to the drinking water of
treated cages (containing two to four mice each). For both treated and untreated
mice, cages and drinking water were replaced after 5 days, and new FTY720 was
added to the treated cages. Groups of four mice per group per time point were
used. No mice were excluded from the analysis. The analysis was performed
without blinding.
γδ thymocyte co-culture with OP9-DL1 cells. For short-term culture of sorted γδ
thymocytes, OP9-DL1 feeder cells were used. OP9-DL1 cells (gift from J.C. Zúñiga-
Pﬂücker55) were maintained at 30–80% conﬂuency in OP9 medium (HEPES-
buffered Glutamax MEM-α (Life Technologies) containing 20% FBS, penicillin/
streptomycin, Na-pyruvate, gentamycin and β-mercaptoethanol) in 10 cc culture
dishes (Nunc, Roskilde, Denmark). On the day before the experiments, OP9-DL1
cultures were set up by adding 3 × 103 OP9-DL1 cells per well of a ﬂat-bottom
96-well plate (Nunc, Roskilde, Denmark) and allowed to form monolayers over-
night. For anti-CD3-treated cultures, the wells were coated with anti-CD3 prior to
seeding OP9-DL1 cells by adding 5 µg per mL anti-CD3 antibody (145-2C11 clone;
BioLegend) in PBS to each well and incubated for at least 4 h at 37 °C. The medium
was removed, and 2–10 × 103 sorted γδ thymocytes were suspended in 200 µL OP9
medium containing 5 ng per mL rmIL-7, and 5 ng per mL rhFlt-3L (R&D Systems
Inc., Minneapolis, USA) and added to each well. OP9-DL1 co-cultures are known
to induce artiﬁcial phenomena such as fate switching27, 31, 56. To avoid these
phenomena and limit the risk of selective outgrowth of minor populations, the cells
were only cultured for 2 days before analysis by ﬂow cytometry.
Identiﬁcation of surface marker candidates. MicroArray data from CD24+
CD73−, CD24+CD73+ and CD24-CD73+ Vγ1.1+ and Vγ2+ thymocytes were
acquired through Gene Expression Omnibus (GEO) (GSE75920; Buus et al.31).
Robust multi-array average (RMA) values were calculated from CEL-ﬁles for 'core'
probes using the 'oligo' R package57. Batch effects from the four independent
batches were corrected by adjusting expression values using the ComBat function
('sva' R package)58. Differentially expressed probe sets between the CD24+CD73−
and CD24+CD73+ stages were ﬁltered by exhibiting a log2 fold change greater than
3 and BH adjusted p value below 0.05 using parametric F-test. Differentially
expressed probe sets were subsequently ﬁltered by Gene Ontology terms related to
cell surface expression (GO:0009986 or GO:0005886) and relative log2 expression
greater than 7.
For gene products with commercially available antibodies, the protein
expression and distribution among γδ thymocytes were analysed by ﬂow
cytometry. CD117, CD200 and CD371 were selected for further analysis based on
the following criteria: adequate staining for ﬂow cytometry allowing separation of a
positive and negative population, ability to further divide the CD24+CD73− or
CD24+CD73+ stages and having similar expression pattern within the Vγ1.1+ and
the Vγ2+ subsets when divided into the CD24+CD73−, CD24+CD73+ and CD24
−CD73+ stages.
Flow cytometry. Antibodies against mouse CD3 (145-2C11), CD4 (RM4-5), CD8
(53-6.7), CD5 (53-7.3), CD9 (MZ3), CD24 (M1/69), CD25 (PC61), CD27
(LG.3A10), CD44 (IM7), CD45RB (C363-16A), CD62L (MEL-14), CD73 (TY/
11.8), CD117 (2B8), CD121a (JAMA-147), CD122 (TM-β1), CD127 (A7R34),
CD154 (MR1), CD160 (eBioCNX46-3), CD186 (221002), CD192 (475301), CCR6
(29-2L17), CD199 (9B1), CD200 (OX-90), CD200R (OX-110), CD314 (C7),
CD371 (5D3/CLEC12A), JAML (4E10), Ly-6C (HK1.4), TCRδ (GL-3), TCRβ
(H57-597), TCRVγ1.1 (2.11), TCRVγ2 (UC3-10A6), TCRVδ6.3/2 (8F4H7B7),
TCRVδ4 (GL2) and NK1.1 (PK136) were purchased from BD Biosciences
(Franklin Lakes, NJ, USA), BioLegend (San Diego, CA, USA) or eBioscience (San
Diego, CA, USA). See Supplementary Table 1 for full list of antibody conjugates.
Fixable viability dye (eFluor780 or eFluor506; eBioscience, San Diego, CA, USA) or
7-AAD (BioLegend, San Diego, CA, USA) was used to exclude dead cells in the
analysis.
Single-cell suspensions from thymus or inguinal lymph nodes (LN) were
generated by disruption and straining through a 70-µm cell strainer with a rubber
plunger from a 5-mL syringe. Thymic cell suspensions were enriched for γδ T cells
by depleting them with anti-CD4 and anti-CD8 magnetic beads (Miltenyi Biotec).
For all ﬂow cytometry staining, antibodies were diluted in brilliant stain buffer (BD
Biosciences, San Diego, CA, USA; cat. no. 563794) and stained for 30–40 min in the
dark on ice. For intracellular cytokine staining, single-cell suspensions were
stimulated with phorbol 12-myristate 13-acetate (PMA; 25 ng per mL) and
ionomycin (625 ng per mL) in complete medium including monensin (2.08 µg per
mL) for 4 h at 37 °C. Cells were stained for surface markers, ﬁxed and
permeabilised using BD Cytoﬁx/Cytoperm (BD Biosciences; cat. no. 554722).
Permeabilised cells were stained with anti-IL-17A (TC11-18H10), anti-IFN-γ
(XMG1.2), anti-PLZF (9E12), anti-AHR (T49-550) and anti-RORγ(t) (B2D) or a
rat IgG1 isotype control. All samples were analysed on a BD LSRFortessa or BD
Aria II at the Core Facility for Flow Cytometry, Faculty of Health and Medical
Sciences, University of Copenhagen. Data were analysed using the R or FlowJo
software (Treestar, Ashland, OR, USA).
Sorting γδ thymocytes. γδ thymocytes from eight mice were isolated and stained
for ﬂow cytometry as described above. To sort the 14 different populations, thy-
mocytes were initially sorted into four samples using a yield mask for best recovery:
Vγ1.1+CD73−, Vγ1.1+CD73+, Vγ2+CD73− and Vγ2+CD73+ cells. Each of these
four samples were subsequently sorted as A, B and C or D, E, F and G populations
directly into TRI reagent (cat. no. T9424, Sigma-Aldrich) for RNA sequencing
(RNA-Seq) or OP9 medium for co-culture experiments using a purity mask for
optimal purity. To achieve sufﬁcient cells for RNA-sequencing libraries, RNA was
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pooled from two or three independent sorting experiments, each using thymi from
eight mice. Due to the limited number of cells and direct lysis, post-sort purity was
assayed only from the largest population (Vγ2+ B) and found to consistently exceed
95%. Cell lysates in TRI reagent were stored at −80 °C after ﬁnal sorting until RNA
extraction.
mRNA sequencing. Cell lysates in TRI reagent were thawed at room temperature,
and RNA was extracted by adding BCP (cat. no. B9673, Sigma-Aldrich), cen-
trifugation and using the upper phase. RNA was precipitated with isopropanol and
washed twice with 70% ethanol. RNA samples were resuspended in nuclease-free
water and stored at −80 °C until library construction. RNA-Seq libraries were
constructed using the SMARTer Ultra Low Input RNA v4 (cDNA synthesis and
ampliﬁcation; cat. no. 634890, Takara) and SMARTer Low Input Library Prep Kit
V2 (library prep from cDNA; cat. no. 634899, Takara) according to the protocols
supplied by the vendor. Two biological replicates from each population were
generated and sequenced during separate runs. For both independent biological
replicates, sequencing was conducted as 100-bp paired-end reads divided on two
lanes containing A to G populations from either the Vγ1.1+ or the Vγ2+ subset on
the Illumina HiSeq2500 platform. This division on lanes assured high-ﬁdelity
comparisons of populations within each subset. The quality of the raw RNA-Seq
reads was controlled using FastQC. Library preparation and sequencing were
performed at AROS Applied Biotechnology A/S (Aarhus, Denmark).
Statistics. Unless stated otherwise, statistical analyses were performed using the
two-sided Student’s t test with a 5% signiﬁcance level, unpaired observations and
equal variance. Signiﬁcance was deﬁned as *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
Bioinformatics analysis of ﬂow cytometry data. Equal numbers of γδ T cells
were down-sampled from each replicate, concatenated to a single fcs ﬁle using
FlowJo and used for analysis in R using the 'ﬂowCore' and 'cytofkit' packages59, 60.
t-SNE was calculated for 10,000 cells based on the expression of CD24, CD25,
CD73, CD117, CD200 and CD371. Due to the stochasticity of the algorithm,
multiple t-SNE graphs were generated that showed a highly similar grouping. Cells
were clustered using Phenograph, ClustalX, DensVM and FlowSOM61. FlowSOM
clustering with k = 7 yielded similar-sized clusters with discernible differences in
surface marker expression and was chosen for further analysis. The cluster proﬁle
heat map was created based on the mean expression of cells within each cluster.
Progression analysis was conducted using the Isomap and Diffusionmap algo-
rithms on a cluster-based down-sampled data set, as recommended in the cytofkit
manual.
Bioinformatics analysis of mRNA sequencing. Raw RNA-Seq reads were pseu-
doaligned to the mouse transcriptome (ENSEMBL, GRCm38 release 79) using
Kallisto. Expression analysis was conducted using the 'tximport' and 'DEseq2' R
packages adhering to the guidelines suggested in the DEseq2 manual62, 63. Forty-
one erythrocyte-associated transcripts were excluded due to high erythrocyte
transcription within the V1C_2 sample in comparison to all the other samples
(including its biological replicate V1C_1). The C populations from the second
biological replicates (V1C_2 and V2C_2) clustered closer to their respective D
populations compared with the ﬁrst C population samples, likely due to the small
number of cells and less efﬁcient CD200 staining during sorting, leading to the
inclusion of CD200low-int cells in the C populations of this replicate. To con-
servatively represent the expression within the populations, the mean of the bio-
logical replicates was used in data visualisations. Overall, transcriptional similarity
was used to infer likely developmental relationships between each of the A to G
populations. This tactic assumes that two populations exhibiting low overall
transcriptional difference are more likely to be related than two populations
exhibiting greater difference. Transcriptional differences between the populations
were calculated using their pairwise Euclidian distances as well as by principal
component analysis (PCA) calculated from all expressed RNA-Seq transcripts
using R.
TCR Vδ usage and CDR3 clonotyping. TCR sequence analysis was performed by
aligning RNA-Seq sequences against TCR genes allowing insertions and gaps using
miXCR software with settings optimised for RNA-Seq libraries including two
assemblePartial and one extendAlignments runs, as recommended by the man-
ual64. VDJtools65 was used to eliminate erroneous clonotypes, ﬁlter for functionally
recombined CDR3 sequences (by removing out-of-frame transcripts) and reduce
the number of reads from each library to equal numbers (1200 and 724 aligned
reads per library for CDR3δ and CDR3γ, respectively). The heat maps of enrich-
ment of CDR3 motifs associated with different γδ T cell effector subsets in Fig. 3h
were extracted using 'regular-expressions' and quantiﬁed by dividing by the total
number of ﬁltered reads aligned to the TCR Vδ or TCR Vγ locus in R. The heat
map of TCR Vδ-chain usage in Fig. 4d within each population was calculated by
the number of reads divided by the total number of ﬁltered reads aligned to the
TCR Vδ locus in R. The CDR3 diversity quantiﬁcation included in Supplementary
Fig. 7 was calculated as the inverse Simpson index using the 'tcR' package in R66
and using VDJtools.
Code availability. The code used for analysis in our study is available from the
corresponding author on request.
Data availability. The RNA-Seq data sets used in Figs. 3 and 4 have been deposited
in the GEO under ID code GSE97137. The previously published and publicly
available MicroArray data set used in Fig. 1 is available in the GEO under ID code
GSE75920. All other data are available from the authors on request.
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